Retraction notices

ACP-196, An Orally Bioavailable Covalent Selective Inhibitor of Btk, Modulates the Innate Tumor Microenvironment, Exhibits Antitumor Efficacy and Enhances Gemcitabine Activity in Pancreatic Cancer

Type

Retraction

Notice date

8/31/2017 0:00

Journal

Cancer Research

Publisher

American Association for Cancer Research

Notice DOI

10.1158/0008-5472.can-17-2154

Original paper DOI

10.1158/1538-7445.am2015-408

Reasons

• Investigation by Company/Institution
• Objections by Company/Institution
• Unreliable Data

Matching venue names

Name match only, not an authoritative journal identifier.

• Cancer Research